About
Maxcyte Inc (NASDAQ:MXCT) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026
Mar 31 2026
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 24 2026
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
Mar 23 2026
MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer
Feb 24 2026
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery
Financials
Revenue
$33.03 M
Market Cap
$80.1 M
EPS
-0.42
Google Übersetzer